This text is a result of machine translation.
Pure Global: The International Engine of Medical Technology Globalization
As a pioneer in international regulatory management and clinical solutions, Pure Global has evolved into an indispensable partner for medical technology companies. Through its outstanding data technology, seasoned industry expert team, and transnational capabilities, Pure Global empowers its partners to achieve global growth. Presently, Pure Global's services span more than 25 countries and regions, offering tailored solutions for the entire lifecycle of medical devices.
Sep 28, 2023 09:30 AM
Lansi Technology: the revenue in the first quarter decreased by 22.15% year-on-year, and the profit turned into loss year-on-year
Lansi Technology: the production and operation of the company and some subsidiaries have been affected to varying degrees due to the epidemic
Lansi Technology: strive to achieve a high year-on-year growth in smart wear business in 2022
NaaS and NewLink Partnered with China Construction Bank to Progress New Energy Globally
This strategic partnership is to empower NewLink and NaaS to expand their global presence in the new energy sector, thereby fostering green, low-carbon, and sustainable development in the energy industry.
Sep 28, 2023 09:24 PM
"TopXGun" and "Xingchen Dahai" have both recently closed funding rounds
EqualOcean has learned that recently, TopXGun(拓攻机器人), a civilian manufacturer of large-scale UAVs, announced that it has received C1 round of equity financing led by Archaeus Capital(含元资本). In addition, Hangzhou Xingchen Dahai Technology Co., Ltd (杭州星辰大海科技有限公司)(hereinafter referred to as "Xingchen Dahai"), a technology company focusing on the field of drone countermeasures, has completed tens of millions of dollars of Series A financing.
Sep 28, 2023 06:35 PM
CITIC Securities: driven by Apple's new computer, the performance growth of the industrial chain company in the third quarter has high certainty
EqualOcean|China's Top 20 ESG Performers Among Private Enterprises(Part III)
Sep 28, 2023 10:00 AM